CPVT is generally an autosomal dominant disease and is associated with mutations in the RYR2 (ryanodine receptor/calcium release channel) gene and the recessive form is associated with mutations in CASQ2 (calsequestrin) [34]. Here, CASQ2 is linked to autosomal dominant disease.